154048-89-2 Usage
General Description
(4-Iodo-pyridin-3-yl)-carbamic acid tert-butyl ester is a chemical compound with the molecular formula C11H14IN3O2. It belongs to the class of pyridines, which are heterocyclic aromatic compounds containing a six-membered ring with five carbon atoms and one nitrogen atom. This specific compound is an ester derivative of carbamic acid, containing a tert-butyl group. It is used in organic synthesis and as a building block for the preparation of pharmaceuticals, agrochemicals, and other fine chemicals. The compound has potential applications in medicinal chemistry and drug discovery due to its structural and functional properties. Additionally, it is important to handle and store this chemical in a safe manner to prevent any potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 154048-89-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,0,4 and 8 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 154048-89:
(8*1)+(7*5)+(6*4)+(5*0)+(4*4)+(3*8)+(2*8)+(1*9)=132
132 % 10 = 2
So 154048-89-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H13IN2O2/c1-10(2,3)15-9(14)13-8-6-12-5-4-7(8)11/h4-6H,1-3H3,(H,13,14)
154048-89-2Relevant articles and documents
AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF
-
Paragraph 0577-0580, (2018/07/29)
The present disclosure relates to amine-substituted heterocyclic compounds. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating a disorder (e.g., cancer) via inhibition of a methyltransfera
HEPATITIS C INHIBITORS AND USES THEREOF
-
, (2012/07/13)
This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
3-AMINO-PYRIDINES AS GPBAR1 AGONISTS
-
Page/Page column 157; 158, (2012/09/21)
This invention relates to novel 3-aminopyridines of the formula (I) wherein B1, B2 and R1 to R6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.
